We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Urgent safety updates arising from pharmacovigilance data, including reported adverse events, for veterinary medicines authorised in the UK.
Reported problems with the supply of an animal medicine and the date when the issue is expected to be resolved.
Information about the risks of taking valproate medicines during pregnancy.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Providing vital research into COVID-19 immunity and vaccine effectiveness nationally.
Berwyn is a men’s prison in Wrexham, North Wales.
Guidance for specialists for initiation of valproate in female patients and for annual review and pregnancy testing to support adherence to pregnancy prevention requirements during the pandemic.
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
Prescribing or supplying veterinary medicines including requirements for registration and inspection of premises.
Guidance for veterinary medicines manufacturers and wholesale dealers in GB on selling and supplying products placed on the EU and UK markets before 1 January 2021 and the evidence you may need to provide.
Explainer for businesses and persons regulated by the Veterinary Medicines Regulations 2013, as amended, on the transitional provisions included in the amending legislation: the Veterinary Medicines (Amendment etc.) Regulations 2024.
Information and documents on Public Health England’s review of the evidence for dependence on, and withdrawal from, prescribed medicines.
Information for healthcare professionals and the public about the Pfizer/BioNTech's bivalent vaccines
Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure.
There have been very rare reports of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) with pseudoephedrine.
Safety leaflet to help you understand the latest information about the effects of pregabalin during pregnancy.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).